acepodia announces - Robuta Search

https://www.prnewswire.com/news-releases/acepodia-announces-nobel-laureate-carolyn-bertozzi-phd-as-chief-scientific-advisor-301925960.html Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor Sep 18, 2023 - /PRNewswire/ -- Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and... acepodia announces nobel laureate carolyn bertozzi ph chief https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-investigational-new-drug-application-for-ace1831-in-igg4-related-disease-302306506.html Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in... Nov 15, 2024 - /PRNewswire/ -- Acepodia (6976:TT), a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation... announces fda clearance investigational new acepodia drug application https://www.prnewswire.com/news-releases/acepodia-announces-preliminary-clinical-data-from-phase-1-clinical-trial-of-ace1831-first-ever-anti-cd20-antibody-conjugated-allogenic-gamma-delta-t-cell-therapy-for-non-hodgkins-lymphoma-302139302.html Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever... May 8, 2024 - /PRNewswire/ -- Acepodia (6976:TT), a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation... acepodia announces clinical data preliminary phase trial https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-investigational-new-drug-application-for-ace2016-a-first-in-class-allogeneic-anti-egfr-cell-therapy-302052466.html Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a... Feb 4, 2024 - /PRNewswire/ -- Acepodia (6976:TT), a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation... announces fda clearance investigational new acepodia drug application https://www.acepodia.com/newsroom-detail/acepodia_announces_Emerging_Stock_Listing_Taipei_Exchange/ Acepodia Announces Emerging Stock Listing on The Taipei Exchange-Acepodia® | POWERFUL, ACCESSIBLE... acepodia announces emerging stock listing taipei https://www.prnewswire.com/news-releases/acepodia-announces-fda-clearance-of-ind-application-for-ace1831-an-anti-cd20-armed-allogeneic-gamma-delta-t-cell-therapy-candidate-to-treat-patients-with-non-hodgkins-lymphoma-301570711.html Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic... Jun 20, 2022 - /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC)... announces fda clearance acepodia ind application anti